Cloudera Sets Date to Announce First Quarter Fiscal Year 2021 Results
Get Alerts CLDR Hot Sheet
Join SI Premium – FREE
PALO ALTO, Calif., May 6, 2020 /PRNewswire/ -- Cloudera, Inc. (NYSE: CLDR), the enterprise data cloud company, announced that it will report its first quarter fiscal year 2021 (ended April 30, 2020) financial results on June 3, 2020 after the close of market, and host a conference call to discuss the results at 2:00 PM Pacific Time (5:00 PM Eastern Time).
Conference Call and Webcast Information
The conference call can be accessed as follows:
- Participant Toll Free Number: +1-833-579-0900
- Participant International Number: +1-778-560-2567
- Conference ID: 6993335
A webcast of the conference call can be accessed from the News & Events section of the Company's website at https://investors.cloudera.com/events/Events/default.aspx. A replay of the webcast will be available for at least two weeks following completion of the call.
About ClouderaAt Cloudera, we believe that data can make what is impossible today, possible tomorrow. We empower people to transform complex data into clear and actionable insights. Cloudera delivers an enterprise data cloud for any data, anywhere, from the Edge to AI. Powered by the relentless innovation of the open source community, Cloudera advances digital transformation for the world's largest enterprises. Learn more at cloudera.com.
Cloudera and associated marks are trademarks or registered trademarks of Cloudera, Inc. All other company and product names may be trademarks of their respective owners.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cloudera-sets-date-to-announce-first-quarter-fiscal-year-2021-results-301053701.html
SOURCE Cloudera, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- RENO 2024: Saving Our Wild Horses and Wildlife Conference
- Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!